Table 3.
Tertiles of total follicular fluid AMH concentrations | ||||
---|---|---|---|---|
T1 | T2 | T3 | p valuea | |
FF AMH concentrations, ng/ml | 0.2 (0.1, 0.2) | 0.6 (0.5, 0.9) | 2.3 (1.5, 3.7) | 0.0001 |
Demographics | ||||
Age, years | 36.0 (33.0, 39.0) | 33.0 (31.0, 37.0) | 33.5 (32.0, 37.0) | 0.04 |
Race, N (%) | 0.03 | |||
White | 46 (80) | 54 (91) | 35 (76) | |
Black | 2 (4) | 3 (5) | 0 (0) | |
Asian | 7 (12) | 1 (2) | 8 (17) | |
Other | 2 (4) | 1 (2) | 3 (7) | |
Body mass index, kg/m2 | 24.5 (21.4, 27.5) | 22.6 (20.6, 24.5) | 22.4 (20.5, 25.2) | 0.04 |
Ever smoked, N (%) | 14 (25) | 15 (25) | 9 (20) | 0.75 |
Education, N (%) | 0.12 | |||
High school/some college | 3 (5) | 3 (5) | 6 (13) | |
College graduate | 12 (21) | 23 (39) | 13 (28) | |
Graduate degree | 42 (74) | 33 (56) | 27 (59) | |
Cycle-reproductive characteristics | ||||
Infertility diagnosis, n (%) | 0.30 | |||
Male factor | 26 (36) | 26 (36) | 25 (35) | |
Female factor | 16 (22) | 18 (26) | 19 (27) | |
Diminished ovarian reserve | 5 (7) | 2 (3) | 2 (3) | |
Endometriosis | 3 (4) | 2 (3) | 2 (3) | |
Ovulatory disorders | 3 (4) | 5 (7) | 12 (17) | |
Tubal | 5 (7) | 7 (10) | 3 (4) | |
Uterine | 0 (0) | 2 (3) | 0 (0) | |
Idiopathic | 30 (42) | 27 (38) | 28 (38) | |
Treatment protocol, n (%) | 0.01 | |||
Antagonist | 15 (21) | 11 (15) | 8 (11) | |
Flare | 18 (25) | 8 (11) | 7 (10) | |
Luteal-phase agonist | 39 (54) | 54 (74) | 57 (79) | |
Peak E2, pmol/L | 1982 (1484, 2612) | 1979 (1591, 2643) | 2110 (1557, 2443) | 0.81 |
ICSI cycles, n (%) | 42 (59) | 34 (47) | 45 (63) | 0.12 |
Serum AMH concentrations, ng/ml | 0.1 (0, 0.3) | 0.4 (0.1, 0.8) | 0.6 (0.3, 1.2) | 0.0001 |
Day 3 FSH levels, IU/L | 7.0 (6.3, 8.6) | 6.5 (5.7, 8.0) | 6.4 (5.6, 7.5) | 0.03 |